Targeting the TGF-β RI kinase with LY2157299: A PK/PD-driven drug discovery and clinical development program
Year: 2005
Type: article
Source: Cancer Research
Author: Jonathan M. Yingling
Institution: Eli Lilly (United States)
Language: English
Topic: TGF-β signaling in diseases
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2578524818
